
|Articles|November 1, 2012
Antiandrogen shows efficacy in elderly men with advanced prostate cancer
Bicalutamide monotherapy in men with locally advanced or metastatic prostate cancer is as initially effective as LHRH analogs but can be far more beneficial in preserving bone mineral density, muscle tone, sexual function, and quality of life, say British researchers.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
4
The UroOnc Minute: Variant Histologies in Bladder Cancer, With Carissa Chu, MD
5











